Quotes 5-day view Delayed Nasdaq
06/27/2022
06/28/2022
06/29/2022
06/30/2022
07/01/2022
Date
42.19(c)
40.96(c)
40.87(c)
37.9(c)
38.56(c)
Last
7 140 577
7 825 456
6 099 225
15 611 717
9 291 855
Volume
+1.30%
-2.92%
-0.22%
-7.27%
+1.74%
Change
Estimated financial data (e) (USD)
Sales 2022
132 B
-
-
Net income 2022
5 329 M
-
-
Net Debt 2022
9 035 M
-
-
P/E ratio 2022
6,28x
Yield 2022
4,99%
Sales 2023
135 B
-
-
Net income 2023
3 390 M
-
-
Net Debt 2023
7 348 M
-
-
P/E ratio 2023
9,97x
Yield 2023
5,10%
Capitalization
33 326 M
33 326 M
-
EV / Sales 2022
0,32x
EV / Sales 2023
0,30x
Nbr of Employees
315 000
Free-Float
60,9%
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:
- retail distribution (83.1%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2020, the activity is ensured through 13,449 outlets (including 9,021 in the United...
Ratings of Walgreens Boots Alliance, Inc.
All news about WALGREENS BOOTS ALLIANCE, INC.
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
Walgreens profit plunges on opioid settlement, lower pharmacy sales
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38,56 $
Average target price
44,56 $
Spread / Average Target
15,6%
Please enable JavaScript in your browser's settings to use dynamic charts.